XEROX CORPORATION -- 43P81, 8R3669, PLATEN GLASS, LENS AND MIRROR CLEANER -- -
=====================  Product Identification  =====================

Product ID:43P81, 8R3669, PLATEN GLASS, LENS AND MIRROR CLEANER
MSDS Date:07/23/1998
FSC:NIIN:Submitter:D DG
Status Code:A
=== Responsible Party ===
Company Name:XEROX CORPORATION
Address:100 CLINTON AVE SOUTH
City:ROCHESTER
State:NY
ZIP:14644
Country:US
Info Phone Num:800-828-6571
Emergency Phone Num:716-422-2177
Resp. Party Other MSDS Num.:D-0403A
CAGE:26921
=== Contractor Identification ===
Company Name:XEROX CORPORATION
Address:100 CLINTON AVE SOUTH
Box:City:ROCHESTER
State:NY
ZIP:14644-1877
Country:US
Phone:800-828-6571/716-422-2177
CAGE:26921

=============  Composition/Information on Ingredients  =============

Ingred Name:ETHANOL
CAS:64-17-5
RTECS #:KQ6300000
Minumum % Wt:75.
Maxumum % Wt:85.
OSHA PEL:1900 MG/M3;1000 PPM
ACGIH TLV:1880 MG/M3;1000 PPM
ACGIH STEL:500 PPM

Ingred Name:ISOPROPANOL
CAS:67-63-0
RTECS #:NT8050000
Minumum % Wt:5.
Maxumum % Wt:15.
OSHA PEL:980 MG/M3;400 PPM
ACGIH TLV:983 MG/M3;400 PPM
ACGIH STEL:1230 MG/M3;500 PPM

=====================  Hazards Identification  =====================

LD50 LC50 Mixture:ORAL (RATS) LD50: >21 G/KG.
Reports of Carcinogenicity:NTP:NO    IARC:NO	OSHA:NO
Health Hazards Acute and Chronic:EYES: IRRITATION. SKIN: NOT AN
    IRRITANT NOR A SENSITIZER. PROLONGED OR REPEATED SKIN CONTACT MAY
    CAUSE DEFATTING OF THE SKIN.
Explanation of Carcinogenicity:NO CARCINOGENS PRESENT IN PRODUCT.
Effects of Overexposure:CENTRAL NERVOUS SYSTEM DEPRESSION, RESPIRATORY
    DISTRESS, AND GASTROINTESTINAL IRRITATION.
Medical Cond Aggravated by Exposure:NONE WHEN USED AS DESCRIBED BY
    PRODUCT LITERATURE.

=======================  First Aid Measures  =======================

First Aid:EYES: IMMEDIATELY FLUSH WITH PLENTY OF WATER FOR 15 MINUTES.
    IF IRRITATION PERSISTS, GET MEDICAL ATTENTION. SKIN: WASH
    THOROUGHLY WITH SOAP AND WATER. INHALATION: REMOVE FROM EXPOSURE.
    INGESTION: DILU TE STOMACH CONTENTS WITH SEVERAL GLASSES OF WATER.

=====================  Fire Fighting Measures  =====================

Flash Point Method:TOC
Flash Point:=26.7C, 80.F
Extinguishing Media:ALCOHOL FOAM, CARBON DIOXIDE, WATER FOG, OR DRY
    CHEMICAL.
Fire Fighting Procedures:NONE.
Unusual Fire/Explosion Hazard:NONE.

==================  Accidental Release Measures  ==================

Spill Release Procedures:ESTIMATE SOURCES OF IGNITION. SMALL SPILLS
    SHOULD BE FLUSHED WITH LARGE QUANTITIES OF WATER. LARGE SPILLS
    SHOULD BE ABSORBED ON VERMICULITE OR SIMILAR ABSORBENT MATERIAL,
    AND COLLECTED FOR DISPOSAL.

======================	Handling and Storage  ======================

Handling and Storage Precautions:DO NOT HANDLE OR STORE NEAR HEAT,
    SPARKS, FLAMES, OR OXIDIZING AGENTS. STORE IN A COOL PLACE, AVOID
    PROLONGED OR REPEATED SKIN CONTACT.

=============  Exposure Controls/Personal Protection  =============

Respiratory Protection:NONE REQUIRED WHEN USED AS INTENDED IN XEROX
    PRODUCTS.
Protective Gloves:NITRILE OR LATEX GLOVES. USE FRESH GLOVES WITH EACH
    NEW OPERATION.
Eye Protection:NONE REQUIRED WHEN USED AS INTENDED IN XEROX PRODUCTS.
Other Protective Equipment:NONE.
Supplemental Safety and Health

==================  Physical/Chemical Properties  ==================

HCC:F3
Boiling Pt:=76.C, 168.8F
B.P. Text:76 C TO 82 C.
Vapor Pres:15 MM HG @20C
Vapor Density:0.85(AIR=1
Spec Gravity:0.82
VOC Pounds/Gallon:780
pH:10.6
Evaporation Rate & Reference:3.1 (N-BUTYLACETATE= 1)
Solubility in Water:COMPLETELY.
Appearance and Odor:CLEAR LIQUID(ALCOHOLIC ODOR.
Percent Volatiles by Volume:100 %(WT)

=================  Stability and Reactivity Data  =================

Stability Indicator/Materials to Avoid:YES
ACETYL CHLORIDE, OXIDIZERS.
Hazardous Decomposition Products:NONE.
Conditions to Avoid Polymerization:WILL NOT OCCUR.

===================  Toxicological Information	===================

Toxicological Information:ORAL LD50: >21 G/KG (RATS). DERMAL LD50: >20
    G/KG (RABBITS). INHALATION LC50: N/D. EYE IRRITATION: IRRITANT.
    SKIN SENSITIZATION:NOT A SENSITIZER. SKIN IRRITATION: NOT AN
    IRRITANT. HUMAN PATCH: NON-IRR ITATING, NON-SENSITIZING.
    MUTAGENICITY:N.D. CARCINOGENS: NONE PRESENT. AQUATIC LC50: N.D.
    ADDITIONAL INFORMATION: PROLONGED OR REPEATED SKIN CONTACT MAY
    CAUSE DEFATTING OF THE SKIN. TLV: 1000 PPM (ETH YL ALCOHOL), 400
    PPM (ISOPROPYL ALCOHOL). PEL: 1000 PPM (ETHYL ALCOHOL), 400 PPM
    (ISOPROPYL ALCOHOL). STEL: 500 PPM	(ISOPROPYL ALCOHOL). CEILING:
    N.E. XEROX EXPOSURE LIMIT: N.E.

====================  Disposal Considerations  ====================

Waste Disposal Methods:ABSORB LIQUID ON VERMICULITE OR OTHER ABSORBENT
    MATERIAL OR ATOMIZE INTO AN INCINERATOR WHERE PERMITTED. DISPOSE OF
    IN ACCORDANCE WITH FEDERAL, STATE, AND LOCAL REGULATIONS.

===================  MSDS Transport Information  ===================

Transport Information:D.O.T. PSN: FLAMMABLE LIQUID, N.O.S., (ETHANOL,
    ISOPROPANOL), CLASS 3, UN 1993, PACKING GROUP I I I. EXCEPTION MAY
    APPLY: LIMITED QUANTITY: 49 CFR 173.150(B). CONSUMER COMMODITY,
    ORM-D: 49 CFR 173.150 (B). I.A.T.A. PSN: FLAMMABLE LIQUID, N.O.S.
    (ETHANOL, ISOPROPANOL), CLASS 3, UN 1993, PACKING GROUP I I I .
    I.M.O. PSN: FLAMMABLE LIQUID, N.O.S.(ETHANOL, ISOPROPANOL), CLASS
    3.3, UN 1993, PACKING GROU P I I I.

=====================  Regulatory Information  =====================

SARA Title III Information:ISO PROPANOL (67-63-0): THIS INGREDIENT IS A
    TOXIC CHEMICAL SUBJECT TO THE REPORTING REQUIREMENTS OF SECTION 313
    OF TITLE I I I OF THE SUPERFUND AMENDMENTS AND REAUTHORIAZATION ACT
    OF 1986 AND 40 CFR	PART 372.

=======================  Other Information  =======================

 Disclaimer (provided with this information by the compiling agencies):
 This information is formulated for use by elements of the Department
 of Defense.  The United States of America in no manner whatsoever,
 expressly or implied, warrants this information to be accurate and
 disclaims all liability for its use.  Any person utilizing this
 document should seek competent professional advice to verify and
 assume responsibility for the suitability of this information to their
 particular situation.